======= PPID ======= == Gene Information == * **Official Symbol**: PPID * **Official Name**: peptidylprolyl isomerase D * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5481|5481]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q08752|Q08752]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PPID&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPID|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601753|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Proposed to act as a co-chaperone in HSP90 complexes such as in unligated steroid receptors heterocomplexes. Different co-chaperones seem to compete for association with HSP90 thus establishing distinct HSP90-co-chaperone-receptor complexes with the potential to exert tissue-specific receptor activity control. May have a preference for estrogen receptor complexes and is not found in glucocorticoid receptor complexes. May be involved in cytoplasmic dynein-dependent movement of the receptor from the cytoplasm to the nucleus. May regulate MYB by inhibiting its DNA- binding activity. Involved in regulation of AHR signaling by promoting the formation of the AHR:ARNT dimer; the function is independent of HSP90 but requires the chaperone activity. Involved in regulation of UV radiation-induced apoptosis. Promotes cell viability in anaplastic lymphoma kinase-positive anaplastic large- cell lymphoma (ALK+ ALCL) cell lines. May be involved in hepatitis C virus (HCV) replication and release. {ECO:0000269|PubMed:11350175, ECO:0000269|PubMed:18708059, ECO:0000269|PubMed:19932913, ECO:0000269|PubMed:21711559, ECO:0000269|PubMed:22681779, ECO:0000269|PubMed:23220213, ECO:0000269|PubMed:9659917}. |Pro isomerase| |cellular response to UV-A| |viral release from host cell| |response to UV-A| |exit from host| |movement in environment of other organism involved in symbiotic interaction| |movement in host environment| |exit from host cell| |lipid droplet organization| |cyclosporin A binding| |positive regulation of viral genome replication| |protein refolding| |Hsp90 protein binding| |Hsp70 protein binding| |estrogen receptor binding| |peptidyl-prolyl cis-trans isomerase activity| |protein peptidyl-prolyl isomerization| |chaperone-mediated protein folding| |heat shock protein binding| |peptidyl-proline modification| |positive regulation of viral life cycle| |cellular response to UV| |regulation of viral genome replication| |positive regulation of viral process| |cellular response to light stimulus| |unfolded protein binding| |response to UV| |regulation of viral life cycle| |interaction with host| |cellular response to radiation| |viral life cycle| |regulation of viral process| |regulation of symbiosis, encompassing mutualism through parasitism| |protein folding| |positive regulation of protein secretion| |positive regulation of peptide secretion| |response to light stimulus| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |transcription factor binding| |positive regulation of secretion by cell| |positive regulation of protein transport| |positive regulation of secretion| |response to radiation| |positive regulation of establishment of protein localization| |regulation of protein secretion| |regulation of peptide secretion| |positive regulation of multi-organism process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |viral process| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of multi-organism process| |symbiotic process| |regulation of secretion| |interspecies interaction between organisms| |nucleolus| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |apoptotic process| |positive regulation of transport| |regulation of protein localization| |programmed cell death| |cell death| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |locomotion| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |protein transport| |negative regulation of cellular biosynthetic process| |peptide transport| |regulation of apoptotic process| |negative regulation of biosynthetic process| |protein-containing complex assembly| |regulation of programmed cell death| |amide transport| |establishment of protein localization| |regulation of cell death| |negative regulation of gene expression| |nitrogen compound transport| |protein-containing complex subunit organization| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.81| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.86| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.94| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|2.06| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|2.12| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.507| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15544 * **Expression level (log2 read counts)**: 5.43 {{:chemogenomics:nalm6 dist.png?nolink |}}